34
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Calciphylaxis in a patient with hypoparathyroidism and MEN-1 syndrome

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Summary

          Calciphylaxis is a rare disorder characterised by the development of painful necrotic skin lesions. Occlusion of cutaneous arterioles due to ectopic calcification leads to potentially life-threatening widespread skin loss. Most cases occur in patients with chronic renal disease, which leads to dysregulation of calcium and phosphate homeostasis. Only a handful of case reports exist describing calciphylaxis occurring in patients without chronic renal disease but with hypoparathyroidism. We report on a unique case of a 53-year-old man with multiple endocrine neoplasia type 1 syndrome and acquired hypoparathyroidism due to total parathyroidectomy who went on to develop calciphylaxis following cardiac surgery.

          Learning points
          • Calciphylaxis most commonly occurs in the context of chronic renal disease but can rarely occur in its absence as a consequence of calcium and phosphate dysregulation.

          • Patients who develop necrotic skin lesions in the presence of hypoparathyroidism require an urgent dermatological opinion.

          • Mortality from calciphylaxis is high, with the majority of deaths occurring secondary to sepsis.

          • Management of calciphylaxis requires a multidisciplinary team approach to manage wound healing, infections and pain.

          • Recovery with full rehabilitation from calciphylaxis can take months to years.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: not found
          • Article: not found

          K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

          (2003)
            • Record: found
            • Abstract: found
            • Article: not found

            Calciphylaxis: natural history, risk factor analysis, and outcome.

            Calciphylaxis is characterized by ischemic cutaneous ulceration, high mortality, and ineffective treatment. We conducted a retrospective study of 64 patients with calciphylaxis (including 49 dialysis patients age- and sex-matched to 98 dialysis controls). The estimated 1-year survival rate of calciphylaxis was 45.8%. Risk factors for calciphylaxis included obesity, liver disease, systemic corticosteroid use, calcium-phosphate product more than 70 mg(2)/dL(2), and serum aluminum greater than 25 ng/mL. Survival rates were similar for 16 patients who received parathyroidectomy and 47 who did not. An estimated 1-year survival rate of 61.6% was observed for 17 patients receiving surgical debridement compared with 27.4% for the 46 who did not (P = .008). The study was limited by its retrospective design and there was no control group for the 15 nondialysis cases. Calciphylaxis is multifactorial and usually fatal. Prevention of calciphylaxis may include correction of risk factors identified in this study. Surgical debridement was associated with improved survival, but parathyroidectomy was not.
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis

              Background Calciphylaxis is a life-threatening complication of chronic kidney disease (CKD). To inform clinical practice, we performed a systematic review of case reports, case series, and cohort studies to synthesize the available treatment modalities and outcomes of calciphylaxis in patients with CKD. Methods Electronic databases were searched for studies that examined the uses of sodium thiosulfate, surgical parathyroidectomy, calcimimetics, hyperbaric oxygen therapy, and bisphosphonates for calciphylaxis in patients with CKD, including end-stage renal disease. For cohort studies, the results were synthesized quantitatively by performing random-effects model meta-analyses. Results A total of 147 articles met the inclusion criteria and were included in the systematic review. There were 90 case reports (90 patients), 20 case series (423 patients), and 37 cohort studies (343 patients). In the pooled cohorts, case series, and case reports, 50.3% of patients received sodium thiosulfate, 28.7% underwent surgical parathyroidectomy, 25.3% received cinacalcet, 15.3% underwent hyperbaric oxygen therapy, and 5.9% received bisphosphonates. For the subset of cohort studies, by meta-analysis, the pooled risk ratio for mortality was not significantly different among patients who received sodium thiosulfate (pooled risk ratio [RR] 0.89; 95% confidence interval [CI] 0.71–1.12), cinacalcet (pooled RR 1.04; 95% CI 0.75–1.42), hyperbaric oxygen therapy (pooled RR 0.89; 95% CI 0.71–1.12), and bisphosphonates (pooled RR 0.77; 95% CI 0.44–1.32), and those who underwent surgical parathyroidectomy (pooled RR 0.88; 95% CI 0.69–1.13). Conclusion This systematic review found no significant clinical benefit of the 5 most frequently used treatment modalities for calciphylaxis in patients with CKD. Randomized controlled trials are needed to test the efficacy of these therapies.

                Author and article information

                Journal
                Endocrinol Diabetes Metab Case Rep
                Endocrinol Diabetes Metab Case Rep
                EDM
                Endocrinology, Diabetes & Metabolism Case Reports
                Bioscientifica Ltd (Bristol )
                2052-0573
                08 December 2023
                01 October 2023
                : 2023
                : 4
                : 23-0009
                Affiliations
                [1 ]Department of Endocrinology , University Hospitals Derby & Burton NHS Trust, Derby, UK
                Author notes
                Correspondence should be addressed to I van Heeswijk; Email: isabelle.vanheeswijk@ 123456nhs.net
                Author information
                http://orcid.org/0000-0002-9152-9828
                http://orcid.org/0000-0003-0994-1977
                Article
                EDM230009
                10.1530/EDM-23-0009
                10762544
                38064896
                75266ce3-4af8-4d4b-a638-bb97dceb8685
                © the author(s)

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                : 17 January 2023
                : 08 November 2023
                Categories
                Adult
                Male
                White
                United Kingdom
                Parathyroid
                Diabetes
                Thyroid
                Men1
                Unique/Unexpected Symptoms or Presentations of a Disease
                Unique/Unexpected Symptoms or Presentations of a Disease

                adult,male,white,united kingdom,parathyroid,diabetes,thyroid,men1,unique/unexpected symptoms or presentations of a disease,december,2023

                Comments

                Comment on this article

                Related Documents Log